No results were found for your search. Please adjust your search term or broaden your search criteria.
Still can't find what you are looking for? We can prepare Custom Research for you.
Targocid is an antibiotic used to treat a variety of bacterial infections. It is a semi-synthetic glycopeptide antibiotic, derived from a natural product, teicoplanin. Targocid is used to treat serious infections caused by Gram-positive bacteria, including methicillin-resistant Staphylococcus aureus (MRSA). It is also used to treat endocarditis, a serious infection of the heart valves. Targocid is available in both intravenous and oral formulations.
The Targocid market is a subset of the global antibiotics market. It is a highly competitive market, with a number of major players. Companies in the Targocid market include Sanofi, Pfizer, Merck, GlaxoSmithKline, and AstraZeneca. Show Less Read more
